Image
Joseph Wu
Professor, Medicine - Cardiovascular Medicine
Professor, Radiology
Member, Bio-X
Director, Cardiovascular Institute
Member, Maternal & Child Health Research Institute (MCHRI)
Faculty Fellow, Sarafan ChEM-H
Member, Stanford Cancer Institute
Member, Wu Tsai Neurosciences Institute
Medical Education: Yale School Of Medicine (1997) CT
Fellowship, UCLA Medical Center, Cardiovascular Medicine (2004)
PhD, UCLA, Molecular & Medical Pharmacology (2004)
MD, Yale University School of Medicine, Medicine (1997)
BS, UCLA, Biology (1993)
Affiliation:
Committee:
Dr. Wu is a board-certified cardiologist. He is the director of the Stanford Cardiovascular Institute and the Simon H. Stertzer, MD, Professor of Medicine and Radiology at Stanford University School of Medicine.
The American Heart Association appointed Dr. Wu as its president for fiscal year 2023-2024.
His clinical interests include adult congenital heart disease and cardiovascular imaging. He strives to help each patient achieve the best possible heart health and quality of life.
To advance heart care, Dr. Wu conducts extensive research, focusing on clinical genomics, stem cells, and drug development. The goals of his research are to enhance our understanding of cardiovascular diseases, accelerate the discovery of new drug treatments, and ensure that every cardiovascular patient will benefit from the best of personalized precision medicine being developed at Stanford Medicine.
Dr. Wu has published more than 600 manuscripts with H-index of 126, and is one of the world’s most highly cited scholars in the field of cardiovascular medicine, stem cells, genomics, and precision medicine. His work has appeared in peer-reviewed journals including Nature, Cell, Science, Nature Medicine, Nature Methods, Science Translational Medicine, Cell Stem Cell, PNAS, Circulation, Journal of the American College of Cardiology, European Heart Journal, and many more. Dr. Wu also educates the heart specialists of the future. More than 50 of his trainees are now principal investigators of clinical or research studies in major academic centers both in the US and internationally.
He has earned numerous honors, including the Distinguished Scientist Award from the American Heart Association, NIH Director’s New Innovator Award, and NIH Director's Transformative Research Award. He also received the Presidential Early Career Award for Scientists and Engineers (PECASE) from the White House Office of Technology.
Dr. Wu is an elected member of the National Academy of Medicine (NAM), National Academy of Inventors (NAI), American Association for the Advancement of Science (AAAS), American Society for Clinical Investigation (ASCI), Association of American Physicians (AAP), Academia Sinica (Taiwan), Association of University Cardiologists (AUC), and American Institute for Medical and Biological Engineering (AIMBE). He is an honorary lifetime member of the Society of Toxicology (SOT).
The American Heart Association appointed Dr. Wu as its president for fiscal year 2023-2024.
His clinical interests include adult congenital heart disease and cardiovascular imaging. He strives to help each patient achieve the best possible heart health and quality of life.
To advance heart care, Dr. Wu conducts extensive research, focusing on clinical genomics, stem cells, and drug development. The goals of his research are to enhance our understanding of cardiovascular diseases, accelerate the discovery of new drug treatments, and ensure that every cardiovascular patient will benefit from the best of personalized precision medicine being developed at Stanford Medicine.
Dr. Wu has published more than 600 manuscripts with H-index of 126, and is one of the world’s most highly cited scholars in the field of cardiovascular medicine, stem cells, genomics, and precision medicine. His work has appeared in peer-reviewed journals including Nature, Cell, Science, Nature Medicine, Nature Methods, Science Translational Medicine, Cell Stem Cell, PNAS, Circulation, Journal of the American College of Cardiology, European Heart Journal, and many more. Dr. Wu also educates the heart specialists of the future. More than 50 of his trainees are now principal investigators of clinical or research studies in major academic centers both in the US and internationally.
He has earned numerous honors, including the Distinguished Scientist Award from the American Heart Association, NIH Director’s New Innovator Award, and NIH Director's Transformative Research Award. He also received the Presidential Early Career Award for Scientists and Engineers (PECASE) from the White House Office of Technology.
Dr. Wu is an elected member of the National Academy of Medicine (NAM), National Academy of Inventors (NAI), American Association for the Advancement of Science (AAAS), American Society for Clinical Investigation (ASCI), Association of American Physicians (AAP), Academia Sinica (Taiwan), Association of University Cardiologists (AUC), and American Institute for Medical and Biological Engineering (AIMBE). He is an honorary lifetime member of the Society of Toxicology (SOT).